David C. Myles - CH. DISCOV. & NON-CLIN DEV OFF at Olema Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Ch. Discov. & Non Clin Dev Off
Issuer Symbol
OLMA on Nasdaq
All Insider Reports
All Insider Reports

David C. Myles - trading volume in the past year for Olema Pharmaceuticals, Inc.

Holdings reported by David C. Myles for Olema Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 542,761 $15,734,641 $28.99 14 Jan 2026 Direct
Common Stock 144,846 $4,104,935 $28.34 12 Jan 2026 Indirect
Stock Option (Right to Buy) 250,000 02 Feb 2026 Direct Common Stock
Performance Stock Options (Right to Buy) 106,250 02 Feb 2026 Direct Common Stock

Transactions reported by David C. Myles for Olema Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.